Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Targeted exogenous gene integration method

An exogenous gene, site-specific integration technology, applied in the field of genetic engineering, can solve problems such as reducing the controllability and safety of transgenes, the complexity of gene expression regulation, and inability to achieve results, so as to eliminate safety concerns and avoid target gene expression. Silence, overcoming the effect of positional effects

Active Publication Date: 2013-01-09
北京科芙兰德生物科学有限责任公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] In order to increase the expression of exogenous genes and overcome the influence of the position effect on the transgene, people have tried a variety of methods, such as adding nuclear matrix attachment elements (MAR), site control elements (LCR), insulators ( Insulator) and other elements to overcome the influence of position effect on exogenous gene expression, but due to the complexity of gene expression regulation, it still cannot achieve good results, and the exogenous gene is still inserted randomly in the genome, which reduces the possibility of transgenesis. controllability and safety, which are still urgent issues to be solved in traditional transgenic research

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Targeted exogenous gene integration method
  • Targeted exogenous gene integration method
  • Targeted exogenous gene integration method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1: as1-casein locus site-directed integration of other target gene targeting vector construction (taking human lysozyme gene as an example)

[0032] 1. Construction of gene targeting vector

[0033] 1.1 Amplification and sequencing of homology arms

[0034] According to the bovine as1-casein sequence (Genebank number: X59856) published by GeneBank, an upstream primer (see SEQ ID NO.1) 5'-ATTT was designed GCGGCCGC TAATGTTCCTGTCATACAACTGTGAAT-3', introduce NotI restriction site; downstream primer (see SEQ ID NO.2) 5'-CC CTCGAG GTCAAGATCTATGTAAGAAAATAAAATAG-3', introduce XhoI restriction site, used to amplify homologous left arm (Left arm, 9354-11939, 2586bp). Simultaneously designed the upstream primer (see SEQ ID NO.3) 5'-ACGC GTC GAC AACCATGAAACTTCTCATCCTTAC-3', introduce SalI restriction site; downstream primer (see SEQ ID NO.4) 5'-ACGC GTCG AC ACATTCTTGGGTATGATAGCACTGC-3' introduced a SalI restriction site to amplify the homologous right arm (Right ...

Embodiment 2

[0058] Example 2: Site-directed integration of as1-casein locus and construction of targeting vectors for other target genes (taking human lactoferrin gene as an example)

[0059] According to the above vector construction method, total mRNA was extracted from human breast tissue, and cDNA was obtained by reverse transcription. The upstream and downstream primers were designed according to the human lactoferrin gene sequence published by NCBI (Genebank number: NM_002343): hLF upstream primer, TGC AAGCTT ACCATGAAACTTGTCT (see SEQ ID NO.13); hLF downstream primer, ACG TCTAGA AGCTGGGCCATCTTCTTCG (see SEQ ID NO. 14). Using the cDNA obtained by reverse transcription as a template, the 2155bp hLF coding region was amplified with high-fidelity enzymes, subcloned into the PCDNA3.1 vector using HindIII and XbaI restriction sites, and sequenced. Sequencing results showed 100% homology with the published sequence. Utilizing upstream primer TGC CTCGAG ACCATGAAACTTGTC (see SEQ ID NO....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a method for site-specific integration of exogenous genes. The exogenous genes are site-specific integrated into the bovine as1-casein locus by gene targeting method and then the exogenous genes can obtain the entire regulatory sequence of as1-casein and the regulatory sequence on casein locus to achieve high efficiency expression of said exogenous genes in bovine mammary gland.

Description

technical field [0001] The invention relates to the field of genetic engineering, in particular to a method for site-specific integration of foreign genes. Background technique [0002] Lysozyme is an important antibacterial factor in human milk. It has a killing effect on most Gram-positive bacteria and some Gram-negative bacteria. It plays an important role in enhancing the immunity of infants and young children. It is also widely used in light industry and food industry. In 2009, the U.S. FDA approved the world's first anti-thrombin transgenic drug produced by mammary gland bioreactor, which marked that the use of transgenic animals to produce recombinant proteins has truly entered the stage of industrialization. [0003] The use of mammary gland bioreactors to produce recombinant proteins has broad market application prospects, but the traditional transgenic technology still has some shortcomings in the research of mammary gland bioreactors. In traditional transgenic r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/85C12N15/63C12P21/02
CPCC12N15/8509A01K2217/206A01K2267/01A01K67/0278A01K2217/072A01K2227/101
Inventor 成功汤波李宁
Owner 北京科芙兰德生物科学有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com